Mebeverine Hydrochloride
Brand names: Colofac, Colofac MR
Mebeverine is an antispasmodic used to relieve the cramping abdominal pain and spasm of irritable bowel syndrome and related gastrointestinal disorders.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a direct relaxant of gastrointestinal smooth muscle, easing spasm without the systemic antimuscarinic effects seen with anticholinergic antispasmodics.
Prescribing in practice
- Avoid in paralytic ileus.
- It has few systemic effects, which makes it a useful option where anticholinergic burden is a concern.
- It is usually taken before meals.
Monitoring
No specific laboratory monitoring is needed; review symptom control and reconsider the diagnosis if pain persists or alarm features develop.
Counselling the patient
- Take this medicine before your meals.
- It works on the gut to ease cramping pain and spasm.
- Tell your doctor if your symptoms change or do not improve.
Evidence & guidelines
An established option for IBS-related abdominal pain in NICE guidance on irritable bowel syndrome.
Reference: NICE CG61 Irritable Bowel Syndrome; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021